Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;19(3):529-540.
doi: 10.1016/j.jsxm.2021.12.012. Epub 2022 Feb 4.

Creation and Psychometric Validation of the Sexual Minorities and Prostate Cancer Scale (SMACS) in Sexual Minority Patients-The Restore-2 Study

Elizabeth J Polter  1 , Nidhi Kohli  2 , B R Simon Rosser  3 , Kristine M C Talley  4 , Christopher W Wheldon  5 , Chris J Hoefer  1 , Morgan Wright  1 , Ryan Haggart  6 , Darry Mitteldorf  7 , Gudrun Kilian  1 , Badrinath R Konety  8 , Michael W Ross  9 , William West  10
Affiliations

Creation and Psychometric Validation of the Sexual Minorities and Prostate Cancer Scale (SMACS) in Sexual Minority Patients-The Restore-2 Study

Elizabeth J Polter et al. J Sex Med. 2022 Mar.

Abstract

Background: Existing measures of sexual functioning in prostate cancer survivors focus primarily on erectile function and do not adequately measure the experiences of sexual minority men.

Aim: To develop and psychometrically evaluate a new scale to measure sexual functioning among sexual minority men with prostate cancer.

Methods: Sexual minority prostate cancer patients (n = 401) completed an online battery of urinary and sexual functioning tests in 2019, including a new 37-item instrument about their sexual functioning post-treatment for prostate cancer.

Outcomes: We used confirmatory factor analysis to determine the construct validity of a new scale including five subscales: a four-factor model for all participants (n = 401) evaluated Sexual Satisfaction, Sexual Confidence, Frequency of Sexual Problems, and Urinary Incontinence in Sex. A single-factor model completed only by participants who had attempted or desired receptive anal sex (n = 255) was evaluated in the fifth subscale: Problematic Receptive Anal Sex. To evaluate criterion validity, we calculated the intercorrelations between each Sexual Minorities and Prostate Cancer Scale (SMACS) subscale and four related scales: the Expanded Prostate Cancer Index Composite-50 (EPIC), the Functional Assessment of Cancer Therapy-Prostate, the Brief Symptom Inventory-18, and the International Consultation on incontinence questionnaire. Cronbach's alphas were calculated to measure internal consistency (ie, reliability).

Results: Cronbach's alpha values ranged from 0.64 to 0.89. Loadings (0.479-0.926) and model fit indices were strong (Root Mean Square Error of Approximation: 0.085, Standardized root mean squared residual: 0.063, comparative fit index: 0.927, Tucker-Lewis Index: 0.907). For criterion validity, Sexual Satisfaction, Sexual Confidence, and Frequency of Sexual Problems were moderately correlated with EPIC function and bother scores (r = 0.50-0.72) and Urinary incontinence in sex correlated moderately with EPIC Urinary Function and International Consultation on incontinence questionnaire scores (0.45-0.56).

Clinical implications: The SMACS can be used by clinicians and researchers to comprehensively measure sexual functioning in sexual minority men, in conjunction with existing scales.

Strengths and limitations: This new scale is validated in a large, geographically diverse cohort of sexual minority cancer survivors and fills an important gap in existing measures of sexual functioning. Limitations include a lack of a validation sample.

Conclusion: The SMACS is a valid and reliable new scale that measures sexual minority men's experience of urinary incontinence in sex, problematic receptive anal sex, and sexual distress. Polter EJ, Kohli N, Rosser BRS, et al. Creation and Psychometric Validation of the Sexual Minorities and Prostate Cancer Scale (SMACS) in Sexual Minority Patients-The Restore-2 Study. J Sex Med 2022;19:529-540.

Keywords: Prostate Cancer; Psychometric; Quality of Life; Sexual Dysfunction, Urinary Incontinence.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors report no conflict of interest.

Figures

Figure 1.
Figure 1.
Original hypothesized factor structure of the sexual minorities and prostate cancer scale (SMACS).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Gray R, Fitch M, Fergus K, et al. Hegemonic masculinity and the experience of prostate cancer: A narrative approach. J Aging Identity 2002;7:43–62.
    1. Helgason ÁR, Adolfsson J, Dickman P, et al. Waning sexual function - the most important disease-specific distress for patients with prostate cancer. Br J Cancer 1996;73:1417–1421. - PMC - PubMed
    1. Lilleby W, Fossa SD, Wæhre HR, et al. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys 1999;43:735–743. - PubMed
    1. Wang Z, Ni Y, Chen J, et al. The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: A systematic review and meta-analysis. World J Surg Oncol 2020;18:1–13. - PMC - PubMed
    1. Lardas M, Liew M, van den Bergh RC, et al. Quality of life outcomes after primary treatment for clinically localised prostate cancer: A systematic review. Eur Urol 2017;72:869–885. - PubMed

Publication types